Literature DB >> 20487615

Responding to the multidrug-resistant tuberculosis crisis: mainstreaming programmatic management to the Philippine National Tuberculosis Programme.

M I D Quelapio1, N R C Mira, R B Orillaza-Chi, V Belen, N Muñez, R Belchez, G E Egos, M Evangelista, R Vianzon, T E Tupasi.   

Abstract

SETTING: The Philippines ranks eighth among 27 priority countries for multidrug-resistant TB (MDR-TB).
OBJECTIVE: To describe a model of public-private partnership in MDR-TB management.
METHODS: An exploratory study of integrating MDR-TB management initiated in private-public mix DOTS into the National TB Programme (NTP).
RESULTS: Recognising that MDR-TB was a threat to DOTS, the Tropical Disease Foundation initiated MDR-TB management in 1999. An official mandate for the integration of MDR-TB services into the NTP was issued by the Department of Health in 2008. With an increased government budget augmented by support from the Global Fund to Fight AIDS, Tuberculosis and Malaria, 1294 MDR-TB patients were placed on treatment from 1999 to 2008. The treatment success rate improved from 64% in 1999 to 75% in 2005. There are now five MDR-TB treatment centres with 181 treatment sites in Metro Manila, and three culture centres. People trained include 12 master trainers, 31 trainers, 25 treatment centre and 381 treatment site staff.
CONCLUSION: Mainstreaming into the NTP of this unique model of MDR-TB management through a dynamic public-private collaboration can be considered best practice in implementation science of an evidence-based intervention leading to change in health care policy and practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20487615

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Ion-pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles.

Authors:  Chintan J Bhanushali; Ahmed S Zidan; Ziyaur Rahman; Muhammad J Habib
Journal:  AAPS PharmSciTech       Date:  2013-08-30       Impact factor: 3.246

Review 2.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

3.  Scaling up global health interventions: a proposed framework for success.

Authors:  Gavin Yamey
Journal:  PLoS Med       Date:  2011-06-28       Impact factor: 11.069

4.  A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control.

Authors:  Rasmus Malmborg; Gillian Mann; S Bertel Squire
Journal:  Int J Equity Health       Date:  2011-11-10

5.  Promoting development and uptake of health innovations: The Nose to Tail Tool.

Authors:  Archna Gupta; Cathy Thorpe; Onil Bhattacharyya; Merrick Zwarenstein
Journal:  F1000Res       Date:  2016-03-16

6.  Western Pacific Regional Green Light Committee: progress and way forward.

Authors:  T Islam; B J Marais; N V Nhung; C-Y Chiang; W W Yew; T Yoshiyama; N R Mira; J van den Broek; R Lumb; N Nishikiori; L B Reichman
Journal:  Int J Infect Dis       Date:  2015-03       Impact factor: 3.623

Review 7.  [Control and management strategies in multidrug-resistant tuberculosis: literature reviewEstrategias de control y atención de la tuberculosis multirresistente: una revisión de la literatura].

Authors:  Jaqueline Garcia de Almeida Ballestero; Mônica Cristina Ribeiro Alexandre D Auria de Lima; Juliana Masini Garcia; Roxana Isabel Cardozo Gonzales; Amélia Nunes Sicsú; Fernando Mitano; Pedro Fredemir Palha
Journal:  Rev Panam Salud Publica       Date:  2019-02-06

8.  Initiation, scale-up and outcomes of the Cambodian National MDR-TB programme 2006-2016: hospital and community-based treatment through an NGO-NTP partnership.

Authors:  Sophan Sam; Adrienne E Shapiro; Thim Sok; Sokhan Khann; Rassi So; Sopheap Khem; Sokhem Chhun; Sarith Noun; Bonamy Koy; Prum Chhom Sayouen; Chun Im Sin; Heng Bunsieth; Tan Eang Mao; Anne E Goldfeld
Journal:  BMJ Open Respir Res       Date:  2018-06-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.